Graviton Bioscience logo

Graviton Bioscience Funding & Investors

New York, NY

Graviton Bioscience is a clinical-stage drug discovery and development firm focused on creating and developing therapies for the treatment of CNS, autoimmune, fibrotic, and other significant disorders in which ROCK2 plays a critical role in pathology.

gravitoncorp.com

Total Amount Raised: $64,819,496

Graviton Bioscience Funding Rounds

  • Private Equity

    $24,999,998

    Private Equity Investors

    Enavate Sciences
    sanofi-aventis

  • Series Unknown

    $39,819,496

    Series Unknown Investors

    Pontifax
Funding info provided by Diffbot.